跳至主要内容
临床试验/NCT00476918
NCT00476918Unknown1 期

Dosage Dependency of Intravitreal Triamcinolone Acetonide for Treatment of Diabetic Macular Edema

Heidelberg University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2006年7月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
60
试验地点
2
主要终点
Visual acuity, no of treatments, duration of efficacy

研究概览

简要总结

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a low dosage.

详细描述

Patients with diabetic retinopathy suffer from visual acuity loss caused by diabetic macular edema. Intravitreal injected Triamcinolone Acetonide (steroid) reduces macular edema and increases visual acuity. The duration of its effect is however limited. Therefore, several injections are necessary.

In this study a dosage dependency of triamcinolone acetonide (high dosage vs low dosage) is performed. The primary outcome parameters are the number of treatments and the efficacy of each injection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diabetic macular edema and visual acuity between 20/200 and 20/40 age over 18 years

排除标准

  • recent treatment with laser photocoagulation or intravitreal drugs

结局指标

主要结局

Visual acuity, no of treatments, duration of efficacy

时间窗: 12 months

次要结局

  • intraocular pressure, retinal thickness(12 months)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Intravitreal Triamcinolone Acetonide for Diabetic... | 临床试验